GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
GlaxoSmithKline Pharmaceuticals has received a Final Order from the TDS Authority (INT Tax Circle 2(3)(2)) raising a demand of Rs 2.01 Crores for Assessment Year 2020-2021. The demand consists of Rs 1.11 Crores in TDS and Rs 0.90 Crores in interest under Section 201 of the Income Tax Act. The order was dated 31st March 2026. The company has stated there is no impact on its financial statements as it is contesting the order and plans to file an appeal before the appellate authority. The company has not admitted to any violation.
The tax demand is relatively small compared to GSK Pharma's size and the company is contesting it, so material impact on financials or stock price is unlikely. Shareholders should monitor the appeal outcome, but this is a routine tax dispute and not a structural concern.